Literature DB >> 20061724

Efficacy of low-dose isotretinoin in acne vulgaris.

Kabir Sardana1, Vijay K Garg.   

Abstract

Low-dose isotretinoin (0.5 mg/kg/day) is a mode of therapy for mild to moderate grades of acne. We analyzed the various trials of this mode of therapy with or without combination with topical agents. We also statistically analyzed the results, efficacy and relapse rates of standard therapy in comparison with the low-dose therapy. Our analysis of the data revealed that the efficacy and relapse rates of low-dose isotretinoin in mild to moderate grades of acne is comparable with the standard regimen (1 mg/kg/day), which is given in the severe grade of acne vulgaris. Thus, the grade of acne vulgaris should dictate the dose of administration of isotretinoin and the standard dose of 1 mg/kg/day is an unnecessary overtreatment for mild to moderate grades of acne.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20061724     DOI: 10.4103/0378-6323.58672

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  4 in total

1.  Combination of low-dose isotretinoin and pulsed oral azithromycin in the management of moderate to severe acne: a preliminary open-label, prospective, non-comparative, single-centre study.

Authors:  Dipankar De; Amrinder J Kanwar
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

2.  A randomized comparative trial of two low-dose oral isotretinoin regimens in moderate to severe acne vulgaris.

Authors:  Daulat Ram Dhaked; Ram Singh Meena; Anshul Maheshwari; Uma Shankar Agarwal; Saroj Purohit
Journal:  Indian Dermatol Online J       Date:  2016 Sep-Oct

Review 3.  Isotretinoin; A review on the Utilization Pattern in Pregnancy.

Authors:  Sajad Khiali; Afshin Gharekhani; Taher Entezari-Maleki
Journal:  Adv Pharm Bull       Date:  2018-08-29

4.  Treatment of plane warts with a low-dose oral isotretinoin.

Authors:  Hayder R Al-Hamamy; Husam Ali Salman; Nawar A Abdulsattar
Journal:  ISRN Dermatol       Date:  2012-12-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.